Gain insights into Paysign, Inc.'s Q4 2024 performance, driven by 212% growth in patient affordability revenue.

GoodRx is a top small-cap value stock pick with strong EBITDA, new strategic leadership, and promising growth projected for ...

In 2021, the 30.7 million beneficiaries accounted for over $2 billion in payments for the 101 generic drugs. Under the ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

Dr. Reddy and Alvotech announce the FDA acceptance of the BLA for their proposed biosimilar candidate of Amgen's Prolia and Xgeva for review.

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...

Biosimilars promise comparable therapeutic benefits at significantly lower costs, estimated up to 50–75 per cent. It can not only reduce patients’ financial burdens, but also encourage more people to ...

This milestone underscores our commitment to providing cost-effective, high-quality biosimilars to patients with chronic conditions like psoriasis, expanding access to critical treatments globally,” ...

Here are 20+ unique quotes to inspire young minds and encourage a future where everyone has the chance to succeed. Kriti Barua is a professional content writer who has two years of experience in ...

It was sent to 2,500 patients who had potentially been exposed to bloodborne viruses including HIV, hepatitis B, and hepatitis C due to what the agency described as a failure to properly clean ...